-
1
Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small...
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
2
Evaluation of treatment strategies for patients with stage IIIA non-small cell lung cancer in the immunotherapy era
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
3
Beyond immortality: Epstein–Barr virus and the intricate dance of programmed cell death in cancer development
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
4
Personalized medicine: An alternative for cancer treatment
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
5
Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural c...
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
6
A randomized controlled trial: Effects of compression therapy combined with exercise on chemotherapy-induced peripheral neuropathy in patients with breast cancer
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
7
Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classification
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
8
The emerging role of blood-based biomarkers in early detection of colorectal cancer: A systematic review
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
9
Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
10
Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
11
PARP inhibitors as therapy for small cell lung carcinoma: A systematic review and meta-analysis of clinical trials
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
12
The status of serum 25(OH)D levels is related to breast cancer
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
13
Diagnostic performance of digital breast tomosynthesis (DBT) versus digital mammography (DM) in a population clinically referred for breast imaging – a retrospective cohort study
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
14
Effect of trilaciclib administered before chemotherapy in patients with extensive-stage small-cell lung cancer: A pooled analysis of four randomized studies
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
15
En plaque meningioma of the temporal bone: A systematic review on the imaging and management of a rare tumor
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
16
WGCNA and integrative network analysis identify CHRNA5 and CTLA4 as potential therapeutic targets against angiosarcoma
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
17
Characterization of genomic profiling of Mexican women with breast cancer using EndoPredict
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
18
The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
19
Role of aspirin in cancer prevention
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
20
Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article